SLSN

Business Context and Reporting Period

Company: Nanophase Technologies Corporation (NANX)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2006
Business Overview: Nanophase is a developer and commercial manufacturer of engineered nanomaterials used in sunscreens, personal care, architectural coatings, semiconductor polishing, and industrial applications. The company operates manufacturing facilities in Romeoville and Burr Ridge, Illinois, utilizing proprietary PVS and NanoArc synthesis technologies. It relies heavily on strategic market partners, including BASF, Rohm & Haas Electronic Materials (RHEM), and Altana Chemie, for global distribution and product development.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 32.2% to approximately $9.0 million, driven primarily by increased sales to a new significant customer in architectural coatings and growth in sunscreen/personal care sales to BASF.
• Margin Expansion: Gross profit more than doubled to $1.93 million (21.5% margin) from $974k (14.3% margin). This improvement was attributed to increased revenue volume, favorable product mix, and process efficiencies (38% increase in PVS reactor output), partially offset by rising commodity metal prices.
• Operating Expenses: Selling, General, and Administrative (SG&A) expenses rose to $5.3 million from $4.4 million, largely due to increased stock compensation and professional fees. R&D expenses increased to $2.1 million from $1.9 million.
• Capital Structure: The company raised $5.0 million in August 2006 via a private placement to RHEM. Additionally, a $1.6 million loan from BYK-Chemie USA was utilized for new equipment, with the principal due in 2009.

Guidance, Outlook, and Risks

Outlook and Management Commentary: Management expects continued revenue growth in 2007, driven by end-user adoption in CMP (semiconductor polishing) and fine polishing markets, as well as new product launches with BASF (T-Lite MAX) and Altana. The company anticipates maintaining positive gross margins but notes that net profitability depends on revenue volume absorbing fixed manufacturing costs. Capital spending for 2007 is estimated at approximately $2.5 million.

Key Risks and Contingencies:

• Customer Concentration: Three customers accounted for approximately 88% of 2006 revenue (BASF 56.1%, Architectural Coatings customer 22.1%, RHEM 9.5%). Loss of any major customer would materially harm operations.
• Financial Covenants: The supply agreement with BASF contains a "triggering event" clause. If the company reports a net loss for a 12-month period AND cash/investments fall below $2.0 million, BASF may require a technology license or equipment sale. As of Dec 31, 2006, the company held ~$8.6 million in liquid assets, avoiding this trigger.
• Patent Re-examination: A third party has requested re-examination of a key patent regarding the NanoArc synthesis process. While management believes the risk of material harm is remote, a reduction in patent scope could limit infringement claims.
• Commodity Prices: Significant raw materials are commodity metals; rapid price increases could erode margins if not passed to customers.

Investor Verification Checklist

• Liquidity vs. Covenants: Verify that cash and investment balances remain above the $2.0 million threshold required to avoid the BASF supply agreement triggering event.
• Customer Retention: Monitor revenue concentration and confirm continued order flow from the top three customers (BASF, RHEM, and the architectural coatings partner).
• Patent Status: Track the outcome of the USPTO re-examination proceedings regarding the NanoArc synthesis patent.
• Commodity Exposure: Assess the company's ability to pass through rising raw material costs to customers without losing market share.
• Path to Profitability: Evaluate whether revenue growth is sufficient to cover the high fixed cost structure and reduce the accumulated deficit of $62.7 million.